BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12663495)

  • 1. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.
    Oya M; Takayanagi A; Horiguchi A; Mizuno R; Ohtsubo M; Marumo K; Shimizu N; Murai M
    Carcinogenesis; 2003 Mar; 24(3):377-84. PubMed ID: 12663495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients.
    Ng KL; Yap NY; Rajandram R; Small D; Pailoor J; Ong TA; Razack AH; Wood ST; Morais C; Gobe GC
    Pathology; 2018 Aug; 50(5):511-518. PubMed ID: 29935727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection is associated with the nuclear factor-kappa B p65 signaling pathway in renal cell carcinoma.
    Farhadi A; Namdari S; Chong PP; Geramizadeh B; Behzad-Behbahani A; Sekawi Z; Sharifzadeh S
    BMC Urol; 2022 Feb; 22(1):17. PubMed ID: 35130882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor NF-kappa B in myocardium: developmental expression of subunits and activation by interleukin-1 beta in cardiac myocytes in vitro.
    Norman DA; Yacoub MH; Barton PJ
    Cardiovasc Res; 1998 Aug; 39(2):434-41. PubMed ID: 9798528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
    Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
    Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
    de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
    Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of nuclear factor kappa B in renal cell carcinoma.
    Morais C; Gobe G; Johnson DW; Healy H
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of NF-kappaB activation in normal T cells by supernatant fluid from human renal cell carcinomas.
    Kim HJ; Park JK; Kim YG
    J Korean Med Sci; 1999 Jun; 14(3):299-303. PubMed ID: 10402173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
    Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
    Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
    Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
    Morais C; Healy H; Johnson DW; Gobe G
    Nephrol Dial Transplant; 2010 May; 25(5):1462-74. PubMed ID: 20037166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for the nuclear transcription factor NF-kappa B in the pathogenesis of ureteropelvic junction obstruction.
    Ruiz-Deya G; Sikka SC; Thomas R; Abdel-Mageed AB
    J Endourol; 2002 Oct; 16(8):611-5. PubMed ID: 12470471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
    Li X; Liu J; Park JK; Hamilton TA; Rayman P; Klein E; Edinger M; Tubbs R; Bukowski R; Finke J
    Cancer Res; 1994 Oct; 54(20):5424-9. PubMed ID: 7923175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.
    Sun B; Chen L; Fu H; Guo L; Guo H; Zhang N
    Tumour Biol; 2016 Apr; 37(4):4457-66. PubMed ID: 26500094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
    Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
    Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.
    Qi H; Ohh M
    Cancer Res; 2003 Nov; 63(21):7076-80. PubMed ID: 14612498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.